HSNA COMMERCIALS LTD

Company number 12917874 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

HSNA COMMERCIALS LTD - Analysis Report

Company Number: 12917874

Analysis Date: 2025-07-20 14:00 UTC

Financial Health Assessment for HSNA COMMERCIALS LTD


1. Financial Health Score: B

Explanation:
HSNA Commercials Ltd demonstrates strong financial fundamentals with healthy liquidity and positive net assets growth. The company shows sound working capital management and an improving balance sheet. However, the absence of profit and loss details and the reliance on related-party transactions warrant monitoring. The score "B" reflects a financially stable company with room for improvement in transparency and operational diversification.


2. Key Vital Signs

Metric 2023 Value Interpretation
Fixed Assets £12,000 Small but stable investment in long-term assets; typical for a holding company.
Current Assets £236,183 Strong liquidity position, majority held in cash (£55,357) and debtors (£180,826).
Current Liabilities £58,439 Manageable short-term obligations, significantly lower than current assets indicating positive working capital.
Net Current Assets £177,744 Healthy buffer of liquid assets over liabilities; indicates strong short-term financial health.
Net Assets (Equity) £189,744 Solid equity base; more than tripled since 2022 showing retained earnings growth.
Share Capital £99 Very minimal share capital, typical for small private companies.
Debtors (Receivables) £180,826 High relative to cash, may indicate extended credit terms; needs monitoring for collectability.
Related Party Debtors £170,826 Majority of receivables are due from related companies; suggests intercompany reliance.
Employees Nil No employees reported; suggests holding company structure rather than operational business.

3. Diagnosis: Financial "Vital Signs" and Symptoms

  • Healthy Cash Flow & Working Capital: The company’s cash and current assets comfortably cover its short-term liabilities, indicating no immediate liquidity distress. This is analogous to a patient with strong pulse and blood pressure — the business can meet its current obligations without strain.

  • Asset Stability: Fixed assets remain unchanged, reflecting a stable investment approach consistent with a holding company model. This stability is a positive "bone density" sign but also indicates limited expansion in physical or operational assets.

  • Equity Growth: The equity has grown substantially from £53,777 (2022) to £189,744 (2023), signaling accumulating retained earnings or capital injections. This "muscle gain" is a sign of financial strengthening.

  • Debtor Risk - Related Party Dependence: A notable symptom of potential liquidity risk is the high level of receivables owed by related companies (£170k+). This intercompany exposure could be a "symptom of dependency" which may affect cash flow if related parties face financial stress.

  • Lack of Profit & Loss Disclosure: The absence of P&L details and minimal operational activity (no employees) suggests the company is primarily a holding entity, which limits the ability to assess operational profitability — akin to a patient with unknown vital signs due to missing diagnostic data.

  • No Audit Requirement & Abridged Accounts: The company is within small company thresholds, filing abridged unaudited accounts. While this reduces compliance burden, it limits transparency and external assurance — a mild "blind spot" in financial health diagnosis.


4. Recommendations for Financial Wellness Improvement

  • Improve Receivables Management:
    Closely monitor and manage related party receivables to ensure timely cash conversion. Consider formalizing repayment terms or diversifying receivables to reduce concentration risk. This will strengthen "circulatory system" function by improving cash flow reliability.

  • Enhance Financial Transparency:
    If operationally feasible, provide fuller financial disclosures or audited accounts in future to build stakeholder confidence and enable better financial oversight. Transparency acts as a diagnostic tool for ongoing health monitoring.

  • Consider Capital Structure Review:
    Explore options to increase share capital or introduce external equity if future growth or acquisitions are planned. This would build a stronger "skeletal structure" for funding.

  • Strategic Planning for Diversification:
    As a holding company, consider diversifying investments or operational activities to reduce dependence on related entities and create additional income streams. This reduces systemic risk and improves overall financial resilience.

  • Maintain Compliance and Governance:
    Ensure timely filings and compliance with Companies House requirements to avoid penalties and maintain company status in good standing — akin to regular health check-ups ensuring legal and regulatory well-being.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.